Pre-travel vaccination and medical prophylaxis in the pregnant traveler

Travel Medicine and Infectious Disease

Volumn 6, Issue 5, 2008, Pages 259-275

  Carroll, I Dale ^a   Williams, Damian C ^b  

^a The Pregnant Traveler   (United States)

^b GP Partners at Hall   (United Kingdom)

Author keywords

Diarrhea; Immunization; Malaria; Motion sickness; Pregnancy; Vaccine

Indexed keywords

ACETAZOLAMIDE; ANTHRAX VACCINE; ANTIMALARIAL AGENT; BACTERIAL VACCINE; BCG VACCINE; BRUCELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; FOLIC ACID; HEPATITIS A VACCINE; IMMUNOGLOBULIN; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MENINGITIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE VACCINE; PYRIDOXINE; RABIES VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; TICK BORNE ENCEPHALITIS VACCINE; TYPHOID VACCINE; UNINDEXED DRUG; VARICELLA ZOSTER VACCINE; VIRUS VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ALTITUDE DISEASE; ARTICLE; CHEMOPROPHYLAXIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFECTION; INFORMATION RETRIEVAL; MALARIA; MORBIDITY; MOTION SICKNESS; NONHUMAN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TRAVEL; VACCINATION;

ALTITUDE SICKNESS; DIARRHEA; FEMALE; HUMANS; MALARIA; MOTION SICKNESS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TRAVEL; VACCINES;

EID: 50049103889     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2008.04.005     Document Type: Article

References (132)

1. Brent R.L. Risks and benefits of immunizing pregnant women: the risk of doing nothing. Reprod Toxicol 21 4 (2006 May) 383-389
2. Fischer G.W., Ottolini M.G., and Mond J.J. Prospects for vaccines during pregnancy and in the newborn period. Clin Perinatol 24 1 (1997 Mar) 231-249
3. Gill T.J., Repetti C.F., Metlay L.A., Rabin B.S., Taylor F.H., Thompson D.S., et al. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 72 3 (1983 Sep) 987-996
4. Demicheli V., Barale A., and Rivetti A. Vaccines for women to prevent neonatal tetanus. Cochrane Database Syst Rev 4 (2005 Oct 19) CD002959
5. Ogburn T., Espey E.L., Contreras V., and Arroyo P. Impact of clinical interventions on the rate of influenza vaccination in pregnant women. J Reprod Med 52 9 (2007 Sep) 753-756
6. Van Rie A., Wendelboe A.M., and Englund J.A. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 24 5 Suppl (2005 May) S62-S65
7. Edwards K.M. Pertussis: an important target for maternal immunization. Vaccine 21 24 (2003 Jul 28) 3483-3486
8. Munoz F.M., and Englund J.A. A step ahead. Infant protection through maternal immunization. Pediatr Clin North Am 47 2 (2000 Apr) 449-463
9. Gonik B., Jones T., Contreras D., Fasano N., and Roberts C. The obstetrician-gynecologist's role in vaccine-preventable diseases and immunizations. Obstet Gynecol 96 1 (2000 Jul) 81-84
10. Sprabery L.R. Vaccinations in women. Obstet Gynecol Clin North Am 28 2 (2001 Jun) 189-203
11. Munoz F.M., and Englund J.A. Vaccines in pregnancy. Infect Dis Clin North Am 15 1 (2001 Mar) 253-271
12. ACOG Committee Opinion #282. Immunization during pregnancy. Obstet Gynecol 101 (Jan 2003) 207-212
13. Anon. Guidelines for vaccinating pregnant women from recommendations of the advisory Committee on Immunization Practices (ACIP) (Oct 1998 (Updated May 2007)), Centers for Disease Control
14. Luppi P. How immune mechanisms are affected by pregnancy. Vaccine 21 24 (2003 Jul 28) 3352-3357
15. Fryauff D.J., Cryz S.J., Widjaja H., Mouzin E., Church L.W., Sutamihardja M.A., et al. Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxis. J Infect Dis 177 6 (1998 Jun) 1762-1765
16. Czeizel A.E., and Rockenbauer M. Tetanus toxoid and congenital abnormalities. Int J Gynaecol Obstet 64 3 (1999 Mar) 253-258
17. Kalaca S., Yalcin M., and Simsek Yavuz S. Missed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity. Public Health 118 5 (2004 Jul) 377-382
18. MacLean D.W., and Calder M.A. Pertussis in pregnancy. Scott Med J 26 3 (1981 Jul) 250-253
19. Beiter A., Lewis K., Pineda E.F., and Cherry J.D. Unrecognized maternal peripartum pertussis with subsequent fatal neonatal pertussis. Obstet Gynecol 82 4 Pt 2 Suppl (1993 Oct) 691-693
20. Mooi F.R., and de Greeff S.C. The case for maternal vaccination against pertussis. Lancet Infect Dis 7 9 (2007 Sep) 614-624
21. CDC targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 49 (2000 Jun 9) RR-6
22. Ramsey P.S., and Ramin K.D. Pneumonia in pregnancy. Obstet Gynecol Clin North Am 28 3 (2001 Sep) 553-569
23. Shahid N.S., Steinhoff M.C., Hoque S.S., Begum T., Thompson C., and Siber G.R. Serum breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 346 8985 (1995 Nov 11) 1252-1257
24. CDC typhoid immunization: recommendations of the immunizations practices Advisory Committee (ACIP). MMWR Recomm Rep 43 (1994 Dec 9) RR-14
25. Urganci N., Arapoglu M., Akyildiz B., and Nuhoǧlu A. Neonatal cholestasis resulting from vertical transmission of hepatitis A infection. Pediatr Infect Dis J 22 4 (2003 Apr) 381-382
26. Elinav E., Ben-Dov I.Z., Shapira Y., Daudi N., Adler R., Shouval D., et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 130 4 (2006 Apr) 1129-1134
27. Reinus J.F., and Leikin E.L. Viral hepatitis in pregnancy. Clin Liver Dis 3 1 (1999 Feb) 116-130
28. del Canho R., Grosheide P.M., Mazel J.A., Heijtink R.A., Hop W.C., Gerards L.J., et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 15 15 (1997 Oct) 1624-1630
29. Grosheide P.M., Schalm S.W., van Os H.C., Fetter W.P., and Heijtink R.A. Immune response to hepatitis B vaccine in pregnant women receiving post-exposure prophylaxis. Eur J Obstet Gynecol Reprod Biol 50 1 (1993 Jun) 53-58
30. Silverman N.S., and Greif A. Influenza vaccination during pregnancy. Patients' and physicians' attitudes. J Reprod Med 46 11 (2001 Nov) 989-994
31. Yeager D.P., Toy E.C., and Baker III B. Influenza vaccination in pregnancy. Am J Perinatol 16 6 (1999) 283-286
32. ACOG Committee Opinion #305. Influenza vaccination and treatment during pregnancy. Obstet Gynecol 104 (2004) 1125-1126
33. Sarnat H.B., Rybak G., Kotagal S., and Blair D. Cerebral embryopathy in late first trimester: possible association with swine influenza vaccine. Teratology 20 (1979 Aug) 93-99
34. Heinonen O.P., Slone D., and Shapiro S. Birth defects and drugs in pregnancy (1977), John Wright Publishing Sciences Group Inc., Littleton, Mass p. 314-19, 473-4, 486-7
35. Linder N., Handsher R., Fruman O., Shiff E., Ohel G., Reichman B., et al. Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity. Pediatr Infect Dis J 13 (1994) 959-962
36. Chaturvedi U.S., Mathur A., Chandra A., Das S.K., Tandon H.O., and Singh U.K. Transplacental infection with Japanese encephalitis virus. J Infect Dis 141 (1980) 712-715
37. WHO. Available from:. http://www.who.int/vaccine_research/diseases/vector/en/index1.html
38. Chutivongse S., Wilde H., Benjavongkulchai M., Chomchey P., and Punthawong S. Postexposure rabies vaccination during pregnancy: effect on 202 women and their infants. Clin Infect Dis 20 (1995) 818-820
39. Spence M.R., Davidson D.E., Dill Jr. G.S., Boonthai P., and Sagartz J.W. Rabies exposure during pregnancy. Am J Obstet Gynecol 123 6 (1975 Nov 15) 655-656
40. Varner M.W., McGuinness G.A., and Galask R.P. Rabies vaccination in pregnancy. Am J Obstet Gynecol 143 6 (1982 Jul 15) 717-718
41. Miller E.H., and Wysocki S. Vaccines in women. The Forum 5 2 (2007 Aug) 9-15
42. Merck Pregnancy Registries. Background report on exposure during pregnancy from the Merck Pregnancy Registry for Gardasil (Dec 2006), Merck & Company, North Wales PA. http://www.merckpregnancyregistries.com Available from:
43. WHO. Available from:. http://www.who.int/vaccine_research/diseases/vector/en/index2.html#disease%20burden#disease%20burden
44. Schwartz H.A. Mumps in pregnancy. Am J Obstet Gynecol 60 40 (1950 Oct) 875-876
45. Ylinen O., and Jarvinen P.A. Parotitis during pregnancy. Acta Obstet Gynecol Scand 32 1 (1953) 121-128
46. Greenberg M.W., and Beilly J.S. Congenital defects in the infant following mumps during pregnancy. Am J Obstet Gynecol 57 4 (1949 Apr) 805-806
47. Holowach J., Thurston D.L., and Becker B. Congenital defects in infants following mumps during pregnancy: a review of the literature and a report of chorioretinitis due to fetal infection. J Pediatr 50 6 (1957 Jun) 689-694
48. Aaby P., Bukh J., Lisse I.M., Seim E., and de Silva M.C. Increased perinatal mortality among children of mother's exposed to measles during pregnancy. Lancet 1 8584 (1988 Mar 5) 516-519
49. Chiba M.E., Saito M., Suzuki M., Honda Y., and Yaegashi N. Measles infection in pregnancy. J Infect 47 1 (2003) 40-44
50. De Santis M., Cavaliere A.F., Straface G., and Caruso A. Rubella infection in pregnancy. Reprod Toxicol 21 4 (2006 May) 390-398
51. CDC. Notice to readers: revised ACIP recommendations for avoiding pregnancy after receiving a rubella containing vaccine. MMWR Morb Mortal Wkly Rep 50 49 (2001 Dec 14) 1117
52. Badilla X., Morice A., Avila-Aguero M.L., Saenz E., Cerda I., Reef S., et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr Infect Dis J 26 9 (2007 Sep) 830-835
53. Bar-Oz B., Levichek Z., Moretti M.E., Mah C., Andreou S., and Koren G. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am J Med Genet. 130A 1 (2004 Sep 15) 52-54
54. Burgess M.A. Rubella reinfection-what risk to the fetus?. Med J Aust 156 (1992) 824-825
55. Tan M.P., and Koren G. Chickenpox in pregnancy: revisited. Reprod Toxicol 21 $ (2006 May) 410-420
56. Shields K.E., Galil K., Seward J., Sharrar R.G., Cordero J.F., and Slater E. Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry. Obstet Gynecol 98 (2001) 14-19
57. Robert E. Exposure to yellow fever vaccine in early pregnancy. Vaccine 17 3 (1999 Jan 21) 283-285
58. Nishioka S.d.A. Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study. Trop Med Int Health 3 1 (1998 Jan) 29-33
59. Tsai T.F., Paul R., Lynberg M.C., and Letson G.W. Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis 168 6 (1993 Dec) 1520-1523
60. Nasidi A., Monath T.P., Vandenberg J., Tomori O., Calisher C.H., Hurtgen X., et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg 87 3 (1993 May-Jun) 337-339
61. Suzano C.E., Amaral E., Sato H.K., Papaiordanou P.M., and The Campinas Group on Yellow Fever Immunization during Pregnancy. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Vaccine 24 9 (2006 Feb 27) 1421-1426
62. Laibl V.R., and Sheffield J.S. Tuberculosis in pregnancy. Clin Perinatol 32 3 (2005 Sep) 739-747
63. Pranevicius A., Radzeviciūte V., Bimba P., and Praneviciūte L. Course of pregnancy, delivery and newborn status in case of maternal tuberculosis. [in Lithuanian]. Medicina (Kaunas) 39 4 (2003) 399-402
64. Tripathy S.N., and Tripathy S.N. Tuberculosis and pregnancy. Int J Gynaecol Obstet 80 3 (2003 Mar) 247-253
65. Mazzone T., Celestini E., Fabi R., Pagano M., Serafini M.A., Verdecchia P., et al. Oral typhoid vaccine and pregnancy. Reprod Toxicol 8 3 (1994 May-Jun) 278-280
66. Diop S.A., Manga N.M., Dia N.M., Gaye S., Ndour C.T., Seydi M., et al. Cholera and pregnancy: epidemiological, clinical, and evolutionary aspects. [in French]. Med Mal Infect 37 12 (2007 Dec) 1816-1820
67. Hill D.R., Ford L., and Lalloo D.G. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis 7 3 (2007 Mar) 176-178 author reply 178
68. Tulinius S., and Zachau-Christiansen S. Le probleme des malformations congenitales apres administration du vaccin peroral vivant polio type I aux femmes enceintes de mains de trois mois. Med Hyg 22 (1964) 1075
69. Ornoy A., and Ben Ishai P. Congenital anomalies after oral poliovirus vaccination during pregnancy. Lancet 341 8853 (1993 May 1) 1162
70. Ross L. Congenital anomalies in two infants born after gestational gamma-globulin prophylaxis. Acta Paediatr 84 12 (1995 Dec) 1436-1437
71. Hayakawa F., Imada K., Towatari M., and Saito H. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin. Br J Haematol 118 4 (2002 Sep) 1187-1189
72. Koren G., Money D., Boucher M., Aoki F., Petric M., Innocencion G., et al. Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant women. J Clin Pharmacol 42 3 (2002 Mar) 267-274
73. Kadanali A., Tasyaran M.A., and Kadanali S. Anthrax during pregnancy: case reports and review. Clin Infect Dis 36 10 (2003 May 15) 1343-1346
74. ACOG. Committee on Obstetric Practice. Management of asymptomatic pregnant or lactating women exposed to anthrax. Int J Gynaecol Obstet 77 3 (2002 Jun) 293-295
75. Wiesen A.R., and Little C.T. Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US Army women. JAMA 287 (2002) 1556-1560
76. Green D.M., Reid S.M., and Rhaney K. Generalized vaccinia in the human fetus. Lancet 1 (1966) 1296-1298
77. Khan M.Y., Mah M.W., and Memish Z.A. Brucellosis in pregnant women. Clin Infect Dis 32 8 (2001 Apr 15) 1172-1177
78. WHO. Vector-Borne viral infections. Available from:. http://www.who.int/vaccine_research/diseases/vector/en/index.html
79. Personal communication, Hoffman S. Sanaria Inc.
80. Dawes M., and Chowienczyk P.J. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 15 6 (2001 Dec) 819-826
81. Wangboonskul J., White N.J., Nosten F., ter Kuile F., Moody R.R., and Taylor R.B. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Eur J Clin Pharmacol 44 3 (1993) 247-251
82. McGready R., Ashley E.A., and Nosten F. Malaria and the pregnant traveller. Travel Med Infect Dis 2 3-4 (2004 Aug-Nov) 127-142
83. Ansell J., Hamilton K.A., Pinder M., Walraven G.E., and Lindsay S.W. Short-range attractiveness of pregnant women to Anopheles gambiae mosquitoes. Trans R Soc Trop Med Hyg 96 2 (2002 Mar-Apr) 113-116
84. Rietveld A.E.C. Malaria prevention for special groups: pregnant women, infants and young children. In: Schlagenhauf P. (Ed). Travelers's malaria (2001), BC Decker Inc Hamilton 303-323
85. Gilles H.M. Clinical features of malaria in pregnancy and children. In: Warrell D.A., and Gilles H.M. (Eds). Essential malariology. 4th ed. (2002), Arnold, London
86. Bothelho-Nevers E., Laurencin S., Delmont J., and Pqrola P. Imported malaria in pregnancy: a retrospective study of 18 cases in Marseilles, France. Ann Trop Med Parasitol 99 7 (2005 Oct) 715-718
87. Nosten F., McGready R., Simpson J.A., Thwai K.L., Balkan S., Cho T., et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 354 9178 (1999 Aug 14) 546-549
88. Desai M., ter Kuile F.O., Nosten F., McGready R., Asamoa K., Brabin B., et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7 (2007) 93-104
89. Alecrim W.D., Espinosa F.E.M., and Alecrim M.G.C. Plasmodium falciparum infection in the pregnant patient. Infect Disease Clin North Am 14 1 (2000 Mar) 83-95
90. Phillips-Howard P.A., and Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf 14 3 (1996 Mar) 131-145
91. Wolfe M.S., and Cordero J.F. Safety of chloroquine in chemosuppression of malaria during pregnancy. Br Med J (Clin Res Ed) 290 6480 (1985 May 18) 1466-1467
92. Nyirjesy P., Kavasya T., Axelrod P., and Fischer P.R. Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis. Clin Infect Dis 16 1 (1993 Jan) 127-132
93. Akintonwa A. Placental and milk transfer of chloroquine in humans. Ther Drug Monit 10 2 (1988) 147-149
94. Nosten F., Vincenti M., Simpson J., Yei P., Thwai K.L., de Vries A., et al. The effects of mefloquine treatment in pregnancy. Clin Infect Dis 28 4 (1999 Apr) 808-815
95. Phillips-Howard P.A., Steffen R., Kerr L., Vanhauwere B., Schildknecht J., Fuchs E., et al. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 5 3 (1998 Sep) 121-126
96. Vanhauwere B., Maradit H., and Kerr L. Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. Am J Trop Med Hyg 58 1 (1998 Jan) 17-21
97. Smoak B.L., Writer J.V., Keep L.W., Cowan J., and Chantelois J.L. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen. J Infect Dis 176 3 (1997 Sep) 831-833
98. Na Bangchang K., Davis T.M., Looareesuwan S., White N.J., Bunnag D., and Karbwang J. Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria. Trans R Soc Trop Med Hyg 88 3 (1994 May-Jun) 321-323
99. McGready R., Ashley E.A., Moo E., Cho T., Barends M., Hutagalung R., et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis 192 (2005) 846-853
100. McGready R., Keo N.K., Villegas L., White N.J., Looareesuwan S., and Nosten F. Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg 97 5 (2003 Sep-Oct) 592-594
101. Anonymous. Pyrimethamine combinations in pregnancy. Lancet 2 8357 (1983 Oct 29) 1005-1007
102. Landauer W. Cholinomimetic teratogens. VI. The interaction of cholinomimetic teratogens with the antimalarial drugs chloroquine and chlorguanide. Teratology 17 3 (1978 Jun) 335-340
103. Na-Bangchang K., Manyando C., Ruengweerayut R., Kioy D., Mulenga M., Miller G.B., et al. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women. Eur J Clin Pharmacol 61 8 (2005 Sep) 573-582
104. McGready R., Stepniewska K., Edstein M.D., Cho T., Gilveray G., Looareesuwan S., et al. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol 59 7 (2003 Oct) 545-552
105. Boggild A., Parise M.E., Lewis L.S., and Kain K.C. Atovaquone-Proguanil: Report from the CDC expert meeting on malaria chemoprophylaxis (II). Am J Trop Med Hyg 76 2 (2007 Feb) 208-223
106. Mbaye A., Richardson K., Balajo B., Dunyo S., Shulman C., Milligan P., et al. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae. Am J Trop Med Hyg 74 6 (2006 Jun) 960-964
107. Schaefer C., and Peters P.W. Intrauterine diethyltoluamide exposure and fetal outcome. Reprod Toxicol 6 2 (1992) 175-176
108. McGready R., Hamilton K.A., Simpson J.A., Cho T., Luxemburger C., Edwards R., et al. Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy. Am J Trop Med Hyg 65 4 (2001 Oct) 285-289
109. McGready R., Simpson J.A., Htway M., White N.J., Nosten F., and Lindsay S.W. A double-blind randomized therapeutic trial of insect repellents for the prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 95 2 (2001 Mar-Apr) 137-138
110. Astroff A.B., Freshwater K.J., Young A.D., Stuart B.P., Sangha G.K., and Thyssen J.H. The conduct of a two-generation reproductive toxicity study via dermal exposure in the Sprague-Dawley rat-a case study with KBR 3023 (a prospective insect repellent). Reprod Toxicol 13 3 (1999 May-Jun) 223-232
111. Miyamoto J. Degradation, metabolism and toxicity of synthetic pyrethroids. Environ Health Perspect 14 (1976 Apr) 15-28
112. Meyer A., Stallmach T., Goldenberger D., and Altwegg M. Lethal maternal sepsis caused by Campylobacter jejunei: pathogen preserved in placenta and identified by molecular methods. Mod Pathol 10 12 (1997 Dec) 1253-1256
113. Simor A.E., and Farro S. Campylobacter jejunei infection occurring during pregnancy. Eur J Clin Microbiol Infect Dis 9 2 (1990 Feb) 142-144
114. Goodyer L., and Behrens R.H. Safety of iodine based water sterilization for travelers. J Travel Med 7 1 (2000 Jan) 38
115. Crepin G., Delahousse G., Decocq J., Delcroix M., Caquant F., Querleu D., et al. Danger of iodine drugs in the pregnant woman. [in French]. Phlebologie 31 (1978) 279-285
116. Einarson A., Mastroiacovo P., Arnon J., Ornoy A., Addis A., Malm H., et al. Prospective, controlled, multicentre study of loperamide in pregnancy. Can J Gastroenterol 14 3 (2000 Mar) 185-187
117. Gattuso J.M., and Kamm M.A. Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf 10 1 (1994 Jan) 47-65
118. Quereux C., Morice J., Level G., Ezes H., and Wahl P. Bismuth encephalopathy in pregnant women. Apropos of a case. [in French]. J Gynecol Obstet Biol Reprod (Paris) 5 1 (1976 Jan-Feb) 97-103
119. Loebstein R., Addis A., Ho E., Andreou R., Sage S., Donnenfeld A.E., et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 42 6 (1998 Jun) 1336-1339
120. Larsen H., Nielsen G.L., Schonheyder H.C., Olesen C., and Sorensen H.T. Birth outcome following maternal use of fluoroquinolones. Int J Antimicrob Agents 18 3 (2001 Sep) 259-262
121. Dupont H.L., Jiang Z.D., Okhuysen P.C., Ericsson C.D., de la Cabada F.J., Ke S., et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 142 10 (2005 May 17) 805-812
122. Bertoli D., and Borelli G. Teratogenic action of rifaximin in the rat and rabbit and its effect on perinatal development in the rat. Boll Soc Ital Biol Sper 60 (1984) 1079-1085
123. CDC. Treatment of tuberculosis: American Thoracic Society, CDC and Infectious Diseases Society of America. MMWR Recomm Rep 52 RR-11 (2003 Jun 20) 1-77
124. Bruel H., Poinsot J., and Chabrolle J.P. Neutropenia in a newborn secondary to sulfamethoxazole-trimethoprim administered to the mother. [in French]. Arch Pediatr 6 1 (1999 Jan) 107-108
125. Allen S.J., Okoko B., Martinez E., Gregorio G., and Dans L.F. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2 (2004) CD003048
126. Katz V.L., Peterson R., and Cefalo R.C. Pseudotumor cerebri and pregnancy. Am J Perinatol 6 4 (1989 Oct) 442-445
127. Nakatsuka T., Komatsu T., and Fujii T. Axial skeletal malformations induced by acetazolamide in rabbits. Teratology 45 6 (1992 Jun) 629-636
128. Scott W.J., Hirsch K.S., DeSesso J.M., and Wilson J.G. Comparative studies on acetazolamide teratogenesis in pregnant rats, rabbits, and rhesus monkeys. Teratology 24 1 (1981 Aug) 37-42
129. Merlob P., Litwin A., and Mor N. Possible association between acetazolamide administration during pregnancy and metabolic disorders in the newborn. Eur J Obstet Gynecol Reprod Biol 35 1 (1990 Apr) 85-88
130. Kallen B., and Mottet I. Delivery outcome after the use of meclozine in early pregnancy. Eur J Epidemiol 18 (2003) 665-669
131. Heinonen O.P., and Slone D. Birth defects and drugs in pregnancy (1977), Publishing Sciences Group, Littleton, Massacheusets p. 346-53
132. Ayromlooi J., Tobias M., and Berg P. The effects of scopolamine and ancillary analgesics upon the fetal heart rate recording. J Reprod Med 25 6 (1980 Dec) 323-326